primary hyperuricemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Male, Aged 18-60 years old; (2) Consistent with the diagnosis of hyperuricemia; (3) Drugs that affect blood uric acid metabolism have not been taken recently, including benzothiofuran derivatives (benzbromarone, benzodine), probenecid, colchicine, salicylate (aspirin), selective and nonselective Non-steroidal anti-inflammatory drugs, thiazides, furosemide diuretics, cyclosporine, pyrazinamide, losartan, and other patients who have used other uric acid lowering measures; or discontinued for more than 2 weeks; (4) Cooperate with various research examinations and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Secondary hyperuricemia; (2) Clinical manifestations of gout or gout, including acute gouty arthritis, tophi and chronic arthritis, severe deformity, incapacity, and kidney disease; (3) severe heart, lung, brain, liver, kidney and hematopoietic system comorbidities, including hypertension, hepatitis B or C, kidney stones, polycystic kidney disease, hematological malignancies or other unidentified malignant Disease and HIV; (4) Patients with history of organ transplant or history of cardiopulmonary bypass surgery; (5) Patients who participated in other drug clinical trials within three months; (6) Unwilling to cooperate and mental patients; (7) Allergic constitution and allergy to a variety of drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood uric acid; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum creatinine;urine uric acid;24 hour uric acid excretion index;urine creatinine; | — |
Countries
China
Contacts
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine